Korea University College of Medicine and MFC Sign MOU to Jointly Develop Sarcopenia Treatment for Astronauts
"Expanding Next-Generation Muscle Disease Therapeutic Development Based on Technology Transfer Achievements"
The Myokine Convergence Research Center (MRC) at Korea University College of Medicine announced on the 4th that it has signed a memorandum of understanding (MOU) with MFC for the joint development of a treatment for sarcopenia in astronauts.
From left: Kim Hyunsoo, head of the MRC Center at Korea University College of Medicine, and Hwang Sungkwan, CEO of MFC, pose for a commemorative photo after signing an MOU to jointly develop a treatment for astronaut muscle atrophy. Korea University College of Medicine
View original imageThis agreement is a follow-up collaboration based on the technology cooperation agreement on rare and intractable muscular atrophy diseases and the technology transfer contract for sarcopenia treatments that were signed in 2022. Based on the research and development data accumulated so far, the two sides plan to expand the research scope to space environments and promote the development of next-generation treatments for muscle diseases.
Under the agreement, the two institutions will jointly develop treatments for a wide range of muscle diseases, including research and development of therapeutics for sarcopenia in astronauts, sarcopenia-related cachexia, and Duchenne muscular dystrophy. They will also continue to cooperate across the entire process of pharmaceutical research and commercialization.
Kim Hyunsoo, director of the MRC, said, "We have begun research on therapeutics to maintain the muscle health of astronauts in deep space exploration environments," adding, "Through an integrated myokine research system that can be applied clinically, we will present practical treatment alternatives to patients with sarcopenia and various muscle diseases." MFC CEO Hwang Seonggwan said, "This collaboration will serve as a starting point for the development of next-generation drugs in preparation for the space age."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Meanwhile, the Myokine Convergence Research Center at Korea University College of Medicine opened in October 2023. Focusing on myokines secreted from muscles, the center is pursuing the development of control technologies that can be applied not only to muscle diseases but also to cancer, aging, and degenerative brain diseases.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.